Redsense Medical AB Cash Flow Reinvestment Rate

Latest as of March 2025: 0.14x

Redsense Medical AB cash flow reinvestment rate. Redsense Medical AB (REDS) has a Cash Flow Reinvestment Rate of 0.14x as of March 2025, reinvesting Skr105.00K (capex Skr105.00K ) from operating cash flow of Skr761.00K. Explore Redsense Medical AB debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.14x
(Capex + Investments) / Operating CF

Total Reinvested

Skr105.00K
Capex + Investments

Operating Cash Flow

Skr761.00K
SEK

Capital Expenditures

Skr105.00K
SEK

Cash Flow Reinvestment Rate of Redsense Medical AB (2020–2020)

Cash flow reinvestment rate of Redsense Medical AB from 2020 to 2020. Historical reinvestment intensity for Redsense Medical AB across 1 annual periods. Explore reinvestment intensity of Redsense Medical AB to see what proportion of operating cash flow is directed to capital expenditures.

Redsense Medical AB Cash Flow Reinvestment Rate by Year (2020–2020)

Redsense Medical AB cash flow reinvestment rate by year from 2020 to 2020. Year-by-year capital reinvestment analysis for Redsense Medical AB. For the full cash flow conversion analysis, see Redsense Medical AB cash conversion from operations.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
2020 5.90x Skr101.62 Million Skr17.23 Million Skr37.08 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow